Lysosomal Targeting of β-Cyclodextrin
β-Cyclodextrin (β-CD) and derivatives are approved therapeutics in >30 clinical settings. β-CDs have also shown promise as therapeutics for treatment
Tag: lysosome
HPBCD-enabled metal nanoclusters for selective labeling of lysosomes
The controllable self-assembly of metal nanoclusters (NCs) has attracted great interest because of the morphological versatility and accompanying luminescence properties,
C60-β-cyclodextrin conjugates for enhanced nucleus delivery of doxorubicin
Water-soluble C60-β-cyclodextrin conjugates were prepared to encapsulate and deliver doxorubicin to the cell nucleus. The behaviour of the fullerene aggregates
Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis
Cholesterol crystals (CCs), originally accumulating in the lysosome of cholesterol-laden cells, can aggravate the progression of atherosclerosis. β-cyclodextrin (CD) is
Antiviral effect of C-reactive polymer and methyl beta-cyclodextrin via blocking autophagy through interactions with cell membrane cholesterol
Spanish researchers recently published on the mechanisms involved in antiviral activity of zebrafish C-reactive protein-like protein (CRP1-7) against the spring